首页> 外文期刊>Liver international : >Expression of iron regulatory genes in a rat model of hepatocellular carcinoma.
【24h】

Expression of iron regulatory genes in a rat model of hepatocellular carcinoma.

机译:铁调节基因在肝细胞癌大鼠模型中的表达。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background/Aims: The altered iron metabolism in hepatocellular carcinomas (HCCs), characterized by the iron-deficient phenotype, is suggested to be of importance for tumour growth. However, the underlying molecular mechanisms remain poorly understood. We asked whether these iron perturbations would involve altered expression of genes controlling iron homeostasis. Methods: HCCs were induced in rats by the Solt and Farber protocol of chemical hepatocarcinogenesis, and to evaluate the effects of iron loading, one group of animals were supplemented with dietary iron during tumour progression. Tissue iron contents were determined, labelling indices of S-phase nuclei were calculated, and mRNA levels of iron-regulatory genes were quantitated. Protein levels of ferroportin1 were determined with Western blot. Results: HCCs displayed reduced amount of tissue iron and lack of histologically stainable iron. HCCs expressed significantly higher mRNA levels of genes involved in iron uptake (transferrin receptor-1, divalent metal ion transporter-1), ferroxidase activity (Ferritin-H), and iron extrusion (ferroportin1). The protein levels of ferroportin1 in iron-deficient HCCs were similar as in control livers, and did not increase in HCCs exposed to iron. Hepcidin mRNA levels were decreased in iron-deficient HCCs, rose in response to iron loading and correlated to the tissue iron content. Conclusions: Taken together, the altered expressions of iron-regulatory genes in HCCs possibly reflect an increased demand for bioavailable iron and a high iron turnover in neoplastic cells.
机译:背景/目的:肝细胞癌(HCCs)中铁代谢改变的特征是缺铁表型,对肿瘤的生长很重要。但是,基本的分子机制仍然知之甚少。我们询问这些铁干扰是否会涉及控制铁稳态的基因表达的改变。方法:采用化学肝癌的Solt和Farber方案诱导大鼠肝细胞癌,并评估铁负荷的影响,在一组动物的肿瘤进展过程中为其补充膳食铁。确定组织中的铁含量,计算S期细胞核的标记指数,并定量铁调节基因的mRNA水平。用蛋白质印迹法测定铁转运蛋白1的蛋白水平。结果:肝细胞癌显示组织铁减少,缺乏组织学上可染色的铁。 HCCs表示铁摄取(转铁蛋白受体-1,二价金属离子转运蛋白-1),铁氧化酶活性(Ferritin-H)和铁挤出(ferroportin1)基因的mRNA水平明显升高。铁缺乏型肝细胞癌中ferroportin1的蛋白质水平与对照肝脏相似,暴露于铁的肝癌中其铁蛋白并未增加。铁缺乏的肝癌中铁调素mRNA水平降低,响应铁负荷而上升,并与组织中铁含量相关。结论:综上所述,肝癌中铁调控基因表达的改变可能反映了肿瘤细胞对生物利用铁的需求增加和铁转换率高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号